Prescription weight-management care with Dr Stavy
Weight-management medicines.Considered carefully.
Prescription medicine can be one part of medical weight-management care, but it is not right for everyone. Dr Stavy assesses your health, previous approaches and current treatment before deciding whether prescribing is appropriate. If treatment starts, she also handles monitoring, follow-up and referrals.
- Assessment first
- No medicine is promised before clinical review
- Dr Stavy prescribes
- She makes treatment, monitoring and referral decisions
- Follow-up is individual
- Review timing depends on your stage of care and feedback
Is prescription treatment appropriate for you?
That decision needs a medical assessment. NICE guidance treats weight-management medicines as part of a wider plan, not as a stand-alone shortcut. The decision should take account of your health, other conditions, current medicines and the approaches you have already tried. [1][2]
Your health and goals
Dr Stavy will ask what you would like help with, how weight is affecting your health or daily life, and what you have already tried. A weight measurement or body mass index (BMI), which compares weight with height, does not explain the whole clinical picture. Related health conditions and functional impact also matter. [5]
Your medicines and medical history
Bring a current list of prescribed medicines, over-the-counter products and supplements. Some medicines can affect weight, and a new prescription can interact with existing treatment or alter monitoring needs. Do not stop or change existing prescribed treatment without advice from the clinician responsible for it. [2]
The right route, not a pre-selected product
You do not need to decide which medicine you want before the consultation. Dr Stavy assesses whether prescription treatment is clinically appropriate and discusses reasonable options, alternatives and the monitoring each option would require.
When another service may be better
Some people need input from another specialist or service because of an associated medical, nutritional, psychological or surgical issue. NICE recommends referral where the person’s needs fall outside the appropriate setting. Dr Stavy arranges referrals when they are needed. [3]
One doctor remains responsible for the prescribing decisions.
In Dr Stavy’s weight-management service, she handles the assessment, prescribing decision, monitoring and referrals herself. Follow-up is not sold as one fixed timetable. Its timing depends on your stage of care, how treatment is going and the feedback you give her.
That continuity matters when a plan changes. A starting assessment, an early treatment review and longer-term monitoring can raise different questions. Dr Stavy can review what is helping, any concerns or side effects, changes in other conditions and whether the plan still fits your goals.
This does not mean every person who asks about medicine will receive a prescription. The consultation is the decision point, not a guarantee of treatment.
What should be discussed before prescribing?
A safe prescribing discussion is broader than “which medicine works best?”. It should cover why treatment is being considered, what benefit would be meaningful to you, medicine-specific risks, other options, how progress will be reviewed and what would make the plan change. NICE recommends shared decision-making and regular monitoring. [1][2]
| Question | Why it matters | What happens next |
|---|---|---|
| Why consider medicine now? | Treatment should fit the wider health plan and what has already been tried. | Dr Stavy explains whether prescribing is appropriate or another route is preferable. |
| What are the benefits and risks? | Different medicines have different cautions, adverse effects and monitoring needs. | The medicine-specific discussion happens before a prescription is agreed. |
| What will be monitored? | Weight is only one outcome. Related health conditions, treatment tolerance and personal goals may also need review. | Agree the relevant checks and the next review based on your circumstances. [2] |
| What if treatment is not helping? | A prescription should not continue automatically if the balance of benefit and burden is poor. | Dr Stavy reviews the response and may adjust, stop or change the plan, or refer where appropriate. |
Why this page does not advertise a specific prescription medicine
UK medicines rules allow treatment providers to promote a consultation or service, but prescription-only medicines must not be advertised to the public in a way likely to lead to their use. This page therefore explains the assessment and monitoring service rather than marketing a named medicine or medicine class. [6]
Monitoring is part of treatment, not an afterthought.
NICE recommends regular review of weight-management medicines. The purpose is to check effectiveness, treatment tolerance, adherence to the wider plan and any changes in related health conditions. Other medicines may also need review as health changes. [1][2]
Dr Stavy arranges the timing of follow-up according to your stage of care and the feedback you provide. There is no single interval stated on this page because monitoring should reflect the medicine being considered, your clinical circumstances and what happens after treatment starts.
Tell Dr Stavy about new symptoms, side effects, major changes in appetite or intake, changes in another medical condition, or concerns about continuing treatment. If urgent symptoms occur, use the urgent route advised for that symptom rather than waiting for a routine follow-up appointment.
What does an assessment cost?
Ask the practice to confirm the consultation fee and what it includes before booking. This page does not state a separate medicine-specific tariff. If treatment is prescribed, ask about any additional costs and how follow-up charges work before agreeing to proceed.
The current fees page gives the practice’s published consultation information. For the broader care pathway, Dr Stavy can discuss how prescription treatment fits within medical weight-management care. You can also review testing and diagnostics if investigations are being considered.
If you have type 2 diabetes or another metabolic condition, bring your current management plan. Weight-management treatment should fit safely with the care already in place.
What patients say about Dr Stavy
Read patient feedback in its original context on Google, then compare it with the service, clinician and fee information on this site. Individual reviews describe personal experiences and do not predict clinical outcomes.
Questions about prescription weight-management care
Can I book specifically to discuss weight-management medicine?
Yes. Patients can request an assessment with Dr Stavy specifically to discuss whether prescription weight-management treatment may be appropriate. The appointment is an assessment, not a promise that a medicine will be prescribed. Dr Stavy reviews your health, current medicines, previous approaches and the monitoring that would be needed before making a prescribing decision.
Does an assessment guarantee a prescription?
No. A prescription is not guaranteed. Dr Stavy decides whether treatment is clinically appropriate after assessment and discussion of benefits, risks, alternatives and follow-up. Some people may be better served by another form of weight-management support or by referral to a different specialist service.
Do I need to choose a medicine before the appointment?
No. You can come to the consultation without choosing a product. The purpose of the assessment is to decide whether prescription treatment has a role at all and, if it does, which clinically appropriate option should be discussed. UK rules also mean this public page does not market a particular prescription medicine.
Who monitors treatment?
Dr Stavy handles monitoring within this service. Follow-up timing depends on your stage of care, the treatment plan and the feedback you provide. Reviews can consider treatment tolerance, progress, related health conditions and whether the plan still makes sense. Agree what to monitor and when the next review should happen.
What should I do if I get side effects?
Follow the medicine-specific advice you are given and contact the appropriate clinical service if you are concerned. Severe, persistent abdominal pain can require urgent assessment because some prescription weight-management medicines carry a known but infrequent risk of acute pancreatitis. Do not wait for a routine review if symptoms are severe. [4]
Can treatment fit alongside care from my GP or specialist?
Yes, but responsibilities need to be clear. Tell Dr Stavy which clinicians already manage your health conditions and bring relevant treatment plans or results. Weight-management treatment can affect monitoring needs for other conditions and medicines, so coordination may be important. Continue existing treatment unless the responsible clinician advises a change.
What if prescription treatment is not suitable?
The consultation can still clarify the next step. Dr Stavy may discuss non-prescription approaches, further assessment or referral where another service is more appropriate. The aim is not to force a medicine into the plan. It is to decide what form of care best fits your health needs and current circumstances.
Clinical and regulatory sources
- NICE NG246: Overweight and obesity management — medicines and surgery. Updated 8 January 2026.
- NICE: A guide for prescribing medicines to manage overweight and obesity — overview. Covers assessment, prescribing, monitoring and stopping medicines.
- NICE: When to refer. Referral considerations within adult overweight and obesity management.
- MHRA: updated safety guidance for prescribers and patients, 29 January 2026. Includes the strengthened warning on acute pancreatitis for the relevant medicine class.
- NICE NG246: identifying and assessing overweight, obesity and central adiposity. Includes assessment of comorbidities and avoidance of diagnostic overshadowing.
- MHRA: Medicinal treatment services for weight loss — August 2026, published 9 September 2026. Treatment providers may promote the consultation or service, but must not promote prescription-only medicines to the public.
The sources above support the general clinical and regulatory statements. Dr Stavy’s responsibilities for assessment, prescribing, monitoring, referral and individual follow-up reflect the confirmed practice process. Clinical author: Dr Stavroula Nikitopoulou, GMC 6092503. Independent clinical review: Mr Stefanos Kachrilas, Consultant Urological Surgeon, GMC 7096712.
Start with an assessment, not a product choice.
If you want to discuss whether prescription weight-management treatment may be appropriate, request an assessment with Dr Stavy. Bring your current medicines, relevant results and questions about the wider plan.
Dr StavyWeight-management medicine assessment
Request an assessment